30 reports

  • Rising incidence of bipolar disorder
  • BIPOLAR DISORDER THERAPEUTIC MARKET IN APAC
  • Bipolar Disorder
  • Forecast
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • TREATMENT GUIDELINES FOR BIPOLAR DISORDER
  • RISK FACTORS AND COMORBIDITIES FOR BIPOLAR DISORDER
  • Bipolar Disorder
  • World
  • AstraZeneca PLC
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.

Key Features of the Report: - Bipolar Disorder Patient Flow - Bipolar Disorder Prevalence - Bipolar Disorder Diagnosed Patients - Bipolar Disorder Treated Patients

  • Bipolar Disorder
  • Europe
  • France
  • World
  • Forecast
  • RISK FACTORS AND COMORBIDITIES FOR BIPOLAR DISORDER
  • 3.5 EPIDEMIOLOGICAL FORECAST OF BIPOLAR DISORDER (2014-2024)
  • Bipolar Disorder
  • Germany
  • Japan
  • World
  • Forecast
  • THE ETIOLOGY AND PATHOPHYSIOLOGY OF BIPOLAR DISORDERS
  • TREATMENT GUIDELINES FOR BIPOLAR DISORDER
  • Bipolar Disorder
  • Alexza Pharmaceuticals, Inc.
  • Eli Lilly & Co.
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • THE ETIOLOGY AND PATHOPHYSIOLOGY OF BIPOLAR DISORDERS
  • TREATMENT GUIDELINES FOR BIPOLAR DISORDER
  • Bipolar Disorder
  • Alexza Pharmaceuticals, Inc.
  • Eli Lilly & Co.
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • TREATMENT GUIDELINES FOR BIPOLAR DISORDER
  • THE ETIOLOGY AND PATHOPHYSIOLOGY OF BIPOLAR DISORDERS
  • Bipolar Disorder
  • Alexza Pharmaceuticals, Inc.
  • Eli Lilly & Co.
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • TREATMENT GUIDELINES FOR BIPOLAR DISORDER
  • THE ETIOLOGY AND PATHOPHYSIOLOGY OF BIPOLAR DISORDERS
  • Bipolar Disorder
  • Alexza Pharmaceuticals, Inc.
  • Eli Lilly & Co.
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Marketed Drugs: Bipolar Disorder
  • Definitions of the subtypes of bipolar disorder
  • Bipolar Disorder
  • Europe
  • Japan
  • AstraZeneca PLC
  • Eli Lilly & Co.

Bipolar Disorder Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Bipolar Disorder Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Bipolar Disorder pipeline products,

  • Bipolar Disorder
  • France
  • Germany
  • Italy
  • Market Size

It also provides a comprehensive understanding of the emerging Phase III therapies for Bipolar Disorder (Manic Depression) which can turn out to be future prospective competitors for the marketed products.

  • Bipolar Disorder
  • Depression
  • World
  • Demand
  • Product Initiative

Key Features of the Report: - Bipolar Disorder Patient Flow - Bipolar Disorder Prevalence - Bipolar Disorder Diagnosed Patients - Bipolar Disorder Treated Patients

  • Bipolar Disorder
  • Europe
  • France
  • Germany
  • Forecast
  • 5.4.1 DIAGNOSED BIPOLAR DISORDER PATIENTS
  • GLOBAL SALES FOR BIPOLAR DISORDER BY REGION, 2014-2024
  • Bipolar Disorder
  • Allergan plc
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.

Forecasted growth in the total prevalence of bipolar I disorder and bipolar II disorder will be driven by demographics.

  • Bipolar Disorder
  • Mental Health
  • Europe
  • Japan
  • Demand

Bipolar Disorder Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Bipolar Disorder Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Bipolar Disorder pipeline products,

  • Bipolar Disorder
  • Europe
  • France
  • Germany
  • Market Size

Japan Bipolar Disorder Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Bipolar Disorder Treatments ##) Bipolar Disorder Pipeline ##) Japan Bipolar Disorder Epid

  • Bipolar Disorder
  • Mental Health
  • Pathology
  • Japan
  • Market Size

Italy Bipolar Disorder Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Bipolar Disorder Treatments ##) Bipolar Disorder Pipeline ##) Italy Bipolar Disorder Epid

  • Bipolar Disorder
  • Mental Health
  • Pathology
  • Italy
  • Market Size

Germany Bipolar Disorder Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Bipolar Disorder Treatments ##) Bipolar Disorder Pipeline ##) Germany Bipolar Disorder

  • Bipolar Disorder
  • Mental Health
  • Pathology
  • Germany
  • Market Size

France Bipolar Disorder Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Bipolar Disorder Treatments ##) Bipolar Disorder Pipeline ##) France Bipolar Disorder Ep

  • Bipolar Disorder
  • Mental Health
  • Pathology
  • France
  • Market Size

UK Bipolar Disorder Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Bipolar Disorder Treatments ##) Bipolar Disorder Pipeline ##) UK Bipolar Disorder Epidemiolo

  • Bipolar Disorder
  • Mental Health
  • Pathology
  • United Kingdom
  • Market Size

Spain Bipolar Disorder Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Bipolar Disorder Treatments ##) Bipolar Disorder Pipeline ##) Spain Bipolar Disorder Epid

  • Bipolar Disorder
  • Mental Health
  • Pathology
  • Spain
  • Market Size

US Bipolar Disorder Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Bipolar Disorder Treatments ##) Bipolar Disorder Pipeline ##) US Bipolar Disorder Epidemiolo

  • Bipolar Disorder
  • Mental Health
  • Pathology
  • Market Size
  • SIGNS AND SYMPTOMS OF BIPOLAR DISORDER
  • INCREASE IN PREVALENCE OF BIPOLAR DISORDER
  • Bipolar Disorder
  • Allergan plc
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.
  • TOP COMPANIES PARTICIPATING IN BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS
  • BRAZIL HAS THE HIGHEST NUMBER OF BIPOLAR DISORDER (MANIC DEPRESSION) CLINICAL TRIALS, AS OF APRIL 2017.
  • Bipolar Disorder
  • Clinical Trial
  • Depression
  • Neurology
  • World
  • Bipolar Disorder (Manic Depression) Overview
  • SMALL MOLECULE FOR BIPOLAR DISORDER - DRUG PROFILE
  • Bipolar Disorder
  • Mental Health
  • United States
  • Product Initiative
  • Intra-Cellular Therapies, Inc.
  • Bipolar Disorder (Manic Depression) Overview
  • DRUG FOR BIPOLAR DISORDER - DRUG PROFILE
  • Bipolar Disorder
  • Depression
  • Therapy
  • United States
  • Product Initiative

Promotional Audit Report The ## Key Questions Addressed by this Report: • How many physicians were reached by Seroquel XR through personal promotion in 2016 and how does this compare to its peer set in the Bipolar Disorder, Manic Episodes, and Schizophrenia markets?

  • Bipolar Disorder
  • Health Care Provider
  • Mental Health
  • Pathology
  • United States

Bipolar Disorder Pipeline by Stages ##.

  • Bipolar Disorder
  • Mental Health
  • Product Initiative
  • DEEP TMS SYSTEM - BIPOLAR DISORDER
  • Deep TMS System - Bipolar Disorder Product Overview
  • Bipolar Disorder
  • Clinical Trial
  • Mental Health
  • Neurology
  • Brainsway Ltd.
  • Clinical Trial Profile Snapshots

Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H##, 2016 Reference Code: GDHC##CTIDB Publication Date: JUL 2016 LIST OF TABLES Oppositional Defiant Disorder (ODD) Global Clinical Trials Review, H##, 2016 outlines clinical trials in Oppositional Defiant

  • Bipolar Disorder
  • Mental Health
  • Pathology
  • World
  • Product Initiative